Development and application of statistical models for medical scientific researc
BACKGROUND: After successful treatment of malignant diseases, therapy-related myelodysplastic syndro...
An immune basis for most patients with aplastic anemia (AA) provides a rationale for immunosuppressi...
The outcome of 155 adult aplastic anemia (AA) patients treated with antithymocyte globulin (ATG. Upj...
We aimed to assess the incidence and risk factors of secondary malignancy (SM) in the young adult pa...
BACKGROUND: Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after ...
This follow-up study of a randomized, prospective trial included 192 patients with newly diagnosed s...
This follow-up study of the randomized prospective trial included 192 patients with newly diagnosed ...
BACKGROUND: Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after ...
This follow-up study of a randomized, prospective trial included 192 patients with newly diagnosed s...
<div><p>Background</p><p>Aplastic anemia (AA) is a rare disease in which hematopoietic stem cells ar...
Background and aims. Aplastic anemia (AA) is a rare but life-threatening disease. The introduction o...
We aimed to assess the incidence and risk factors of secondary malignancy (SM) in the young adult pa...
To compare survival rates and long-term complications after bone marrow transplantation (BMT) or tre...
BACKGROUND AND OBJECTIVES: Patients with angioimmunoblastic T-cell lymphoma (AIL) have a poor progno...
133 patients with severe aplastic anemia (SAA) underwent non-T cell–depleted allo-geneic bone marrow...
BACKGROUND: After successful treatment of malignant diseases, therapy-related myelodysplastic syndro...
An immune basis for most patients with aplastic anemia (AA) provides a rationale for immunosuppressi...
The outcome of 155 adult aplastic anemia (AA) patients treated with antithymocyte globulin (ATG. Upj...
We aimed to assess the incidence and risk factors of secondary malignancy (SM) in the young adult pa...
BACKGROUND: Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after ...
This follow-up study of a randomized, prospective trial included 192 patients with newly diagnosed s...
This follow-up study of the randomized prospective trial included 192 patients with newly diagnosed ...
BACKGROUND: Anti-thymocyte globulin (ATG) is used to prevent graft-versus-host disease (GvHD) after ...
This follow-up study of a randomized, prospective trial included 192 patients with newly diagnosed s...
<div><p>Background</p><p>Aplastic anemia (AA) is a rare disease in which hematopoietic stem cells ar...
Background and aims. Aplastic anemia (AA) is a rare but life-threatening disease. The introduction o...
We aimed to assess the incidence and risk factors of secondary malignancy (SM) in the young adult pa...
To compare survival rates and long-term complications after bone marrow transplantation (BMT) or tre...
BACKGROUND AND OBJECTIVES: Patients with angioimmunoblastic T-cell lymphoma (AIL) have a poor progno...
133 patients with severe aplastic anemia (SAA) underwent non-T cell–depleted allo-geneic bone marrow...
BACKGROUND: After successful treatment of malignant diseases, therapy-related myelodysplastic syndro...
An immune basis for most patients with aplastic anemia (AA) provides a rationale for immunosuppressi...
The outcome of 155 adult aplastic anemia (AA) patients treated with antithymocyte globulin (ATG. Upj...
DOI
Add to ORKG